442023 bottle plastic bactec plus aerob
Ended Awarded Last action
- Contract number
- N0018322F0001
- Awardee
-
Becton, Dickinson And Company UEI DP4CNEMUF5F3 Part of Becton, Dickinson And Co
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $291,360
Award facts
- Contract value 100% obligated
- $291,360.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Portsmouth, VA 23708, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $58,272 | |
| Exercise an Option | $0 | |
| Funding Only Action | $58,272 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $58,272 | |
| Exercise an Option | $0 | |
| Funding Only Action | $58,272 | |
| Exercise an Option | $0 | |
| Funding Only Action | $58,272 | |
| Original award | $0 |
About this award
Becton, Dickinson and Company's Infectious Disease Systems division was awarded a delivery order by the Defense Health Agency on October 8, 2021, for BACTEC plastic blood culture bottles—specifically the BACTEC Plus Aerob and BACTEC Peds Plus product lines. This firm fixed-price delivery order, valued at $291,360, represents performance through September 30, 2026, and falls under the GSA Schedule for Critical Analyzers, Laboratory (FSS-66-III) master contract. The award carries no small business set-aside designation and is to be performed in Portsmouth, Virginia. Blood culture bottles are essential consumables within BD's broader BACTEC blood culture system portfolio, which the company supplies extensively to federal healthcare agencies for microbiology diagnostics and infectious disease testing.
This delivery order exemplifies the Defense Health Agency's reliance on established diagnostic suppliers through existing GSA Schedule vehicles, enabling rapid procurement of specialized laboratory consumables critical to military medical operations and federal healthcare delivery. BD's Infectious Disease Systems division maintains a substantial federal contracting presence, including multiple IDIQs and blanket purchase agreements across the Department of Veterans Affairs, National Institutes of Health, and Department of Defense entities. The company's position as a primary supplier of blood culture systems and related reagents to federal agencies reflects its technical expertise in infectious disease diagnostics and established capability to support government healthcare infrastructure requirements.
Quick answers
Who was awarded contract N0018322F0001?
N0018322F0001 was awarded to Becton, Dickinson And Company by Defense Health Agency (Department of Defense) on October 8, 2021.
How much is contract N0018322F0001 worth?
The government has obligated $291,360 on N0018322F0001.
Is contract N0018322F0001 an order under another contract?
Yes. N0018322F0001 is a delivery order under V797D40095, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract N0018322F0001 competed?
The extent of competition for N0018322F0001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award